The Cooper Companies, Inc. (NASDAQ:COO) Shares Purchased by Jennison Associates LLC

Jennison Associates LLC boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 9.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 885,598 shares of the medical device company's stock after purchasing an additional 75,015 shares during the quarter. Jennison Associates LLC owned about 0.44% of Cooper Companies worth $81,413,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. State Street Corp boosted its position in shares of Cooper Companies by 1.2% in the third quarter. State Street Corp now owns 8,590,689 shares of the medical device company's stock worth $947,897,000 after purchasing an additional 104,521 shares during the period. JPMorgan Chase & Co. raised its stake in Cooper Companies by 13.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company's stock valued at $543,979,000 after purchasing an additional 573,908 shares during the period. Geode Capital Management LLC lifted its holdings in Cooper Companies by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company's stock worth $527,476,000 after purchasing an additional 48,559 shares in the last quarter. Victory Capital Management Inc. boosted its stake in Cooper Companies by 23.0% in the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company's stock worth $435,856,000 after purchasing an additional 737,726 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Cooper Companies by 11.9% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company's stock valued at $200,665,000 after buying an additional 194,118 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research report on Friday, December 6th. Morgan Stanley cut their target price on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a research report on Friday, December 6th. StockNews.com downgraded shares of Cooper Companies from a "buy" rating to a "hold" rating in a research note on Wednesday, December 11th. Wells Fargo & Company raised their price target on Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a research note on Friday, December 6th. Finally, Citigroup decreased their price target on shares of Cooper Companies from $116.00 to $115.00 and set a "buy" rating for the company in a research note on Friday, December 6th. Four investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, Cooper Companies has a consensus rating of "Moderate Buy" and a consensus target price of $117.00.

Cooper Companies Stock Performance

Cooper Companies stock traded up $0.90 during mid-day trading on Wednesday, reaching $96.20. 125,066 shares of the company traded hands, compared to its average volume of 1,314,961. The Cooper Companies, Inc. has a fifty-two week low of $84.76 and a fifty-two week high of $112.38. The firm's fifty day moving average is $95.50 and its two-hundred day moving average is $99.77. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The company has a market capitalization of $19.20 billion, a price-to-earnings ratio of 49.33, a price-to-earnings-growth ratio of 2.45 and a beta of 1.00.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, topping analysts' consensus estimates of $1.00 by $0.04. The company had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm's revenue was up 9.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.87 EPS. On average, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.